Medley

Medley R&D per Employee

The R&D Spending per Employee of Medley (4480.T) as of Nov 19, 2026 is 189,973.61 JPY. In the previous year, R&D Spending per Employee was 182,058.05 JPY — a change of 4.35% (higher).

R&D per Employee

189,973.61JPY

YoY

4.35%

Last updated:

R&D Spending per Employee of Medley is 2025 189,973.61 JPY. R&D Spending per Employee of Medley was 2024 182,058.05 JPY. It decreases by 4.35% higher compared to the previous year.

The Medley R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2019
12,031.66 JPY
Jan 1, 2020
178,015.83 JPY
Jan 1, 2021
91,986.81 JPY
Jan 1, 2022
15,831.13 JPY
Jan 1, 2023
23,746.70 JPY
Jan 1, 2024
182,058.05 JPY
Jan 1, 2025
189,973.61 JPY
The Medley R&D per Employee history
YEARR&D per EmployeeYoY
189,973.61JPY+4.35%
182,058.05JPY+666.67%
23,746.70JPY+50.00%
15,831.13JPY-82.79%
91,986.81JPY-48.33%
178,015.83JPY+1,379.56%
12,031.66JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medley Stock analysis

What does Medley do? Medley Inc is a global company specializing in the production and sale of pharmaceutical products. The company was founded in 1985 as a small business and has since become a leading player in the pharmaceutical industry, operating in over 150 countries. Medley Inc produces a variety of products in different areas such as cardiology, gastroenterology, oncology, orthopedics, neurology, and dermatology. The company's business model is based on the development and sale of generic products, which are imitation products of patented drugs. Medley Inc focuses on producing high-quality and effective medicines at competitive prices. The company has production sites in various countries to meet the demand for drugs in each region. In addition to being a manufacturer of medicines, Medley Inc also offers services such as drug distribution, clinical studies, research and development, consulting for pharmaceutical manufacturers, and customer training. The company places great importance on the quality and safety of its products and services and has implemented a comprehensive quality management system to meet its high standards. The product range of Medley Inc includes a variety of drugs used in different indications, including well-known drugs such as Tamoxifen for cancer, Fluoxetine for depression, Oxycodone for pain relief, and Levofloxacin as an antibiotic. Medley Inc strives to make affordable medications accessible to all people and works to improve healthcare worldwide. The company has formed long-term partnerships with organizations and governments in emerging countries to enhance access to affordable medicines. Overall, Medley Inc is a significant player in the pharmaceutical industry, focusing on the production of generics and improving healthcare globally. Through its efforts in quality, innovation, and partnerships, the company aims to have a positive impact on society. Medley is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medley stock

R&D Spending per Employee of Medley is 189,973.61 JPY in 2025.

R&D Spending per Employee of Medley changed from 182,058.05 JPY to 189,973.61 JPY, representing a 4.35% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Medley since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Medley historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Medley

All Key Metrics — Medley